A 34 year-old man with high burden refractory Burkitt’s lymphoma…
Cancer History:
first diagnosis of cancer: 06/2013 cancer type: stage IVb
Therapy gone through:
Chemotherapy: R-CHOP, Hyper CVAD (A+B), ICE, GEMOX
Clinical Trial Number: NCT02247609; enrolled date: 26/02/2014
Interventions: 4th generation CAR targeting CD19, total 420*10e6 cells IV after lymphodepletion with Fludarabine
CRS Grade: 2
Treatment response: CR Quality of Life: improved
Progression-free interval: _3__months
Current status: disease relapsed continued treatment needed
Disease images before and after CART treatment: